Celldex Therapeutics, Inc. (CLDX) Operating income 2016–2025
Celldex Therapeutics, Inc. (CLDX) annual operating income history from SEC filings — each fiscal year as reported.
-$287.4MFY2025 · since FY2016: -$132.9M → -$287.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$287.4M | -47.3% |
| FY2024 | -$195.1M | -26.2% |
| FY2023 | -$154.5M | -34.1% |
| FY2022 | -$115.2M | -61.7% |
| FY2021 | -$71.2M | -12.5% |
| FY2020 | -$63.4M | -15.1% |
| FY2019 | -$55.0M | +64.8% |
| FY2018 | -$156.4M | -28.7% |
| FY2017 | -$121.5M | +8.6% |
| FY2016 | -$132.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice